Literature DB >> 7584988

Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis.

R Kramer1, Y Zhang, J Gehrmann, R Gold, H Thoenen, H Wekerle.   

Abstract

Nerve-specific autoimmune T lymphocytes were used as vehicles to deliver therapeutically useful neurotrophic factors across the endothelial blood-nerve barrier. P2 protein-reactive T-lymphocyte lines from Lewis rats were transduced with a recombinant retrovirus containing the mouse nerve growth factor (NGF) gene. The engineered T cells released high amounts of NGF dependent on antigenic stimulation in vitro. After intravenous injection, the T cells infiltrated the rat peripheral nervous system and persisted there for at least two weeks. Local release of NGF from engineered T cells was demonstrable by immunocytochemistry and by an anti-inflammatory effect on infiltrating macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584988     DOI: 10.1038/nm1195-1162

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  12 in total

1.  Gene therapy in the treatment of autoimmune diseases.

Authors:  G C Tsokos; G T Nepom
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 3.  New strategies in the management of Guillain-Barré syndrome.

Authors:  Jinting Xiao; Alain R Simard; Fu-Dong Shi; Junwei Hao
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 4.  Molecular pathogenesis of neuroinflammation.

Authors:  M Bradl; R Hohlfeld
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

Review 5.  Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection.

Authors:  Eero Castrén
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

6.  The generation of NGF-secreting primary rat monocytes: a comparison of different transfer methods.

Authors:  Lindsay A Hohsfield; Stephan Geley; Markus Reindl; Christian Humpel
Journal:  J Immunol Methods       Date:  2013-03-05       Impact factor: 2.303

7.  Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

Authors:  M K Shaw; J B Lorens; A Dhawan; R DalCanto; H Y Tse; A B Tran; C Bonpane; S L Eswaran; S Brocke; N Sarvetnick; L Steinman; G P Nolan; C G Fathman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

8.  Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells.

Authors:  P M Mathisen; M Yu; J M Johnson; J A Drazba; V K Tuohy
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

9.  Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

Authors:  M Kerschensteiner; E Gallmeier; L Behrens; V V Leal; T Misgeld; W E Klinkert; R Kolbeck; E Hoppe; R L Oropeza-Wekerle; I Bartke; C Stadelmann; H Lassmann; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

10.  Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.

Authors:  P Villoslada; S L Hauser; I Bartke; J Unger; N Heald; D Rosenberg; S W Cheung; W C Mobley; S Fisher; C P Genain
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.